“…When IFN-I is administered to HIV-, simian immunodeficiency virus (SIV)-, or feline immunodeficiency virus (FIV)-infected individuals clinical signs are seen to improve [30, 33, 60, 106, 117], supporting the hypothesis that type I IFNs play important roles in the response to these retroviruses, as well as to other retroviruses, such as HTLV-I [46, 79, 117], BLV [78], feline leukemia virus (FeLV) [28, 149], or MuLV [2, 52]. …”